Ophthalmology Market Research Reports & Industry Analysis
Ophthalmology Industry Research & Market Reports
-
Age-related Macular Degeneration (AMD) - Pipeline Insight, 2024
... the Age-related Macular Degeneration (AMD) market. A detailed picture of the Age-related Macular Degeneration (AMD) pipeline landscape is provided, which includes the disease overview and Age-related Macular Degeneration (AMD) treatment guidelines. The assessment part of ... Read More
-
Astigmatism - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Astigmatism treatment guidelines. The assessment part of the report embraces in-depth Astigmatism commercial assessment and clinical assessment of the Astigmatism pipeline products from the pre-clinical ... Read More
-
Ocular Pain - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Ocular Inflammation and Pain - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Europe Ophthalmic Drugs Market 2023-2030
... United Kingdom, Poland, Germany, and the Rest of Europe are studied in this report. Germany is experiencing positive growth in the ophthalmic market due to an increase in age-related macular degeneration, cataracts, and other eye ... Read More
-
Latin America Ophthalmic Drugs Market 2023-2030
... the Rest of Latin America are examined in this report. The ophthalmic drugs market in Latin America is witnessing robust growth as the demand for ophthalmic medications is rising. Additionally, the collaborations between healthcare providers ... Read More
-
Middle East And Africa Ophthalmic Drugs Market 2023-2030
... years 2023-2030. The United Arab Emirates (UAE), Saudi Arabia, Turkey, and the Rest of the Middle East & Africa are the countries studied in this report. Amidst healthcare challenges in South Africa, eye health requires ... Read More
-
North America Ophthalmic Drugs Market 2023-2030
... and the United States are analyzed in this report. The United States is witnessing steady growth in the ophthalmic drugs market. An increasing prevalence of eye diseases, advancements in the technology of drug delivery, investments ... Read More
-
Thyroid eye disease - Pipeline Insight, 2024
... disease market. A detailed picture of the Thyroid eye disease pipeline landscape is provided, which includes the disease overview and Thyroid eye disease treatment guidelines. The assessment part of the report embraces in-depth Thyroid eye ... Read More
-
Ocular Neuropathic Pain/Corneal Neuropathic Pain - Pipeline Insight, 2024
... growth prospects across the Ocular Neuropathic Pain/Corneal Neuropathic Pain market. A detailed picture of the Ocular Neuropathic Pain/Corneal Neuropathic Pain pipeline landscape is provided, which includes the disease overview and Ocular Neuropathic Pain/Corneal Neuropathic Pain ... Read More
-
Acute optic neuritis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Myopia - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Myopia: Understanding ... Read More
-
Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2024
... Pain Post Cataract Surgery pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Age-related vision dysfunction - Pipeline Insight, 2024
... dysfunction market. A detailed picture of the Age-related vision dysfunction pipeline landscape is provided, which includes the disease overview and Age-related vision dysfunction treatment guidelines. The assessment part of the report embraces in-depth Age-related vision ... Read More
-
Geographic Atrophy (GA)- Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Glaucoma - Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Glaucoma ... Read More
-
Uveitic Glaucoma - Pipeline Insight, 2024
... picture of the Uveitic Glaucoma pipeline landscape is provided, which includes the disease overview and Uveitic Glaucoma treatment guidelines. The assessment part of the report embraces in-depth Uveitic Glaucoma commercial assessment and clinical assessment of ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034
... and these cases are going to increase during the forecast period (2023–2034). This increase in growth can be attributed to growing awareness, ultimately leading to an increase in the diagnosed prevalence of FECD. According to ... Read More
-
Chronic Ocular Pain - Pipeline Insight, 2024
... Pain market. A detailed picture of the Chronic Ocular Pain pipeline landscape is provided, which includes the disease overview and Chronic Ocular Pain treatment guidelines. The assessment part of the report embraces in-depth Chronic Ocular ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034
... regarding mental illness and improvements in diagnosis. During the initial phases of schizophrenia, symptoms lack specificity and coincide with other mental health issues or typical fluctuations in behavior. Disease diagnosis is often delayed due to ... Read More
-
Age Related Macular Degeneration - Pipeline Insight, 2024
... the Age Related Macular Degeneration market. A detailed picture of the Age Related Macular Degeneration pipeline landscape is provided, which includes the disease overview and Age Related Macular Degeneration treatment guidelines. The assessment part of ... Read More
-
Retinitis Pigmentosa (RP) - Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for RP. The treatment guidelines for RP have been well established globally. Roche’s Luxturna (voretigene neparvovec) dominate the RP market. Majority of RP pipeline assets are ... Read More
-
Cell and Gene Therapies in Ophthalmology
... pigmentosa (retinitis) and Leber congenital amaurosis (LCA), is marketed globally, and is the only gene therapy on the market within the ophthalmology space. All other marketed CGTs are cell therapies. Holostem Terapie Avanzate’s Holoclar is ... Read More
-
Global Ophthalmology Electronic Medical Records Software Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... and market growth of the Ophthalmology Electronic Medical Records Software industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Ophthalmology Electronic Medical Records ... Read More
-
Global Ophthalmic Finishing Equipment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 3050.7 million by 2030 with a CAGR of 6.6% during review period. The increasing prevalence of vision disorders such as myopia, hyperopia, astigmatism, ... Read More
Research Assistance
